Spiro Rombotis

Insider Reports History

Entity
Individual
Location
C/O Cyclacel Pharmaceuticals, Inc., 200 Connell Drive, Suite 1500, Berkeley Heights, NJ
Signature
/s/ Spiro Rombotis
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Spiro Rombotis:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cyclacel Pharmaceuticals, Inc. President and CEO, Director Common Stock 68.7K $228K $3.32 Dec 21, 2023 Direct
Cyclacel Pharmaceuticals, Inc. President and CEO, Director Stock Option (right to buy) 110K Jun 30, 2023 Direct
Cyclacel Pharmaceuticals, Inc. President and CEO, Director Warrants (right to buy) 6.07K Dec 21, 2023 Direct

Insider Reports Filed by Spiro Rombotis

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CYCC Cyclacel Pharmaceuticals, Inc. Dec 21, 2023 2 $20.1K 4 Dec 26, 2023 President and CEO, Director
CYCC Cyclacel Pharmaceuticals, Inc. Jun 30, 2023 1 $0 4 Jul 3, 2023 President and CEO, Director
CYCC Cyclacel Pharmaceuticals, Inc. Jan 31, 2023 1 $0 4 Feb 2, 2023 President and CEO, Director
CYCC Cyclacel Pharmaceuticals, Inc. Dec 13, 2021 1 $0 4/A Dec 16, 2021 President and CEO, Director
CYCC Cyclacel Pharmaceuticals, Inc. Nov 18, 2021 1 $18K 4 Nov 22, 2021 President and CEO, Director